← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
La Jolla Infectious Disease Institute
San Diego, CA
$3,948,138
Total funding
8
Grants
Funding over time
peak $729.9K · FY2010–22$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,948,138 · 8
By mechanism
R21$2,113,000 · 4
R01$1,447,088 · 2
R03$388,050 · 2
Investigators at La Jolla Infectious Disease Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Microparticles, a new player in cerebral malaria pathogenesis$341,250
R01 · FY2012 · NS
Microparticles, a new player in cerebral malaria pathogenesis$341,250
R01 · FY2015 · NS
Microparticles, a new player in cerebral malaria pathogenesis$337,838
R01 · FY2014 · NS
Microparticles, a new player in cerebral malaria pathogenesis$329,306
R01 · FY2013 · NS
Exploring a new mechanism for thrombocytopenia in experimental malaria$309,000
R21 · FY2019 · AI
Citrulline protects against cerebral malaria by reducing metabolic encephalopathy$295,500
R21 · FY2014 · NS
Citrulline adjunctive therapy for cerebral malaria$292,500
R21 · FY2011 · NS
Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria$260,000
R21 · FY2022 · AI
Exploring a new mechanism for thrombocytopenia in experimental malaria$257,500
R21 · FY2018 · AI
Citrulline protects against cerebral malaria by reducing metabolic encephalopathy$246,250
R21 · FY2015 · NS
Citrulline adjunctive therapy for cerebral malaria$243,750
R21 · FY2010 · NS
Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria$208,500
R21 · FY2021 · AI
Role of platelet CD40 in experimental cerebral malaria coagulopathy$97,500
R03 · FY2010 · AI
RBC-derived microparticles function in cerebral malaria$97,500
R03 · FY2013 · NS
Brain vascular dysfunction in cerebral malaria$97,444
R01 · FY2018 · HL
Role of platelet CD40 in experimental cerebral malaria coagulopathy$96,525
R03 · FY2011 · AI
RBC-derived microparticles function in cerebral malaria$96,525
R03 · FY2014 · NS